Global comparison of the membrane subproteomes between a multidrug-resistant Acinetobacter baumannii strain and a

Axel Siroy1, Pascal Cosette, Damien Seyer

  • 1IBBR Group, Laboratory Polymères, Biopolymères, Membranes, UMR 6522 CNRS, University of Rouen, France.

Insights

This study identifies 135 cell envelope proteins in Acinetobacter baumannii, revealing differences in a multidrug-resistant (MDR) strain. These changes, including altered proteins and biofilm formation, may explain its resistance.

Area of Science:

  • Microbiology
  • Proteomics
  • Infectious Diseases

Background:

  • Acinetobacter baumannii is a significant cause of severe infections, particularly in immunocompromised patients.
  • Understanding the bacterial cell envelope is crucial for developing new therapeutic strategies against resistant strains.

Purpose of the Study:

  • To characterize the cell envelope proteome of Acinetobacter baumannii.
  • To compare the membrane subproteome of a multidrug-resistant (MDR) clinical isolate with a reference strain.
  • To identify potential factors contributing to multidrug resistance and virulence.

Main Methods:

  • Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
  • Two-dimensional gel electrophoresis
  • Liquid chromatography-tandem mass spectrometry (LC-MS/MS)
  • Matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) mass spectrometry

Main Results:

  • Identification of 135 inner and outer membrane proteins.
  • The MDR strain exhibited lower penicillin-binding protein 1b levels and structural variations in the CarO protein compared to the reference strain.
  • The MDR strain showed increased expression of OmpW isoforms and outer membrane proteins (OMPs) like NlpE and CsuD, associated with biofilm formation and adhesion.

Conclusions:

  • The observed proteomic differences, including altered OMPs and enhanced biofilm formation, may contribute to the multidrug resistance of the clinical Acinetobacter baumannii isolate.
  • This proteomic analysis provides insights into the mechanisms underlying Acinetobacter baumannii pathogenesis and resistance.
  • Targeting these identified proteins could offer novel therapeutic avenues against Acinetobacter baumannii infections.

Related Concept Videos